Page last updated: 2024-09-04

phosphorus and 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3

phosphorus has been researched along with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3 in 3 studies

Compound Research Comparison

Studies (phosphorus)	Trials (phosphorus)	Recent Studies (post-2010) (phosphorus)	Studies (26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3)	Trials (26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3)	Recent Studies (post-2010) (26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3)
48,074	1,126	17,139	45	5	3

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Izumi, M; Kiriyama, T; Morii, H; Nagata, A; Nagataki, S; Okamoto, S; Suzuki, H	1
DeLuca, HF; Ikekawa, N; Kobayashi, Y; Tanaka, Y	1
Ito, H; Kinugasa, E; Ogata, H; Shishido, K; Taguchi, S; Takahashi, J; Takahashi, K; Yamamoto, M	1

Trials

1 trial(s) available for phosphorus and 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3

Article	Year
Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. Clinical nephrology, 2009, Volume: 71, Issue:6 Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Calcitriol; Calcium; Collagen Type I; Cross-Over Studies; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Treatment Outcome	2009

Article

Year

Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial.

Clinical nephrology, 2009, Volume: 71, Issue:6

Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Calcitriol; Calcium; Collagen Type I; Cross-Over Studies; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Treatment Outcome

2009

Other Studies

2 other study(ies) available for phosphorus and 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3

Article	Year
Biological activity of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 in the chick. Acta endocrinologica, 1989, Volume: 121, Issue:4 Topics: Animals; Calcitriol; Chickens; Cytosol; Femur; Intestinal Mucosa; Male; Phosphorus; Radiography; Vitamin D Deficiency	1989
26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3: a highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3. Archives of biochemistry and biophysics, 1984, Feb-15, Volume: 229, Issue:1 Topics: Animals; Biological Transport; Bone and Bones; Calcitriol; Calcium; Carrier Proteins; Duodenum; Kinetics; Male; Minerals; Phosphorus; Rats; Receptors, Calcitriol; Receptors, Steroid; Rickets; Vitamin D-Binding Protein	1984

Article

Year

Biological activity of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 in the chick.

Acta endocrinologica, 1989, Volume: 121, Issue:4

Topics: Animals; Calcitriol; Chickens; Cytosol; Femur; Intestinal Mucosa; Male; Phosphorus; Radiography; Vitamin D Deficiency

1989

26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3: a highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3.

Archives of biochemistry and biophysics, 1984, Feb-15, Volume: 229, Issue:1

Topics: Animals; Biological Transport; Bone and Bones; Calcitriol; Calcium; Carrier Proteins; Duodenum; Kinetics; Male; Minerals; Phosphorus; Rats; Receptors, Calcitriol; Receptors, Steroid; Rickets; Vitamin D-Binding Protein

1984